Robert Clisdell

Direktor/Vorstandsmitglied bei APPETISE (HOLDINGS) LIMITED

Consumer Services

Electronic Technology

Technology Services

Aktive Positionen von Robert Clisdell

Unternehmen	Position	Beginn	Ende
APPETISE (HOLDINGS) LIMITED	Direktor/Vorstandsmitglied	-	-
Bergen Capital Australia, LLC	Corporate Officer/Principal	-	-
Koligo Therapeutics Ltd. Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia.	Direktor/Vorstandsmitglied	-	-
Brentridge Capital Pty Ltd.	Vorstandsvorsitzender	01.10.2014	-

Unternehmen	Position	Beginn	Ende
HALO FOOD CO. LIMITED	Direktor/Vorstandsmitglied	01.12.2017	17.02.2022
ONE CLICK GROUP LIMITED	Direktor/Vorstandsmitglied	12.03.2018	23.10.2020
DRONESHIELD LIMITED	Direktor/Vorstandsmitglied	24.01.2017	16.01.2020

The University of Sydney

Undergraduate Degree

International

Australien	8
Japan	2

Operativ

Director/Board Member	5
Undergraduate Degree	1
Corporate Officer/Principal	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
DRONESHIELD LIMITED	Electronic Technology
ONE CLICK GROUP LIMITED	Technology Services
HALO FOOD CO. LIMITED	Consumer Non-Durables

Private Unternehmen	4
Appetise (Holdings) Ltd. Appetise (Holdings) Ltd. Catalog/Specialty DistributionRetail Trade Appetise (Holdings) Ltd. engages in online and mobile application takeaway and delivery restaurant marketplace. It allows takeaway and delivery restaurants to make their menu available to the customers through a platform. It provides ordering and payment platform to enable consumers to choose their food and pay online. The company was founded in 2008 and is headquartered in Sydney, Australia.	Retail Trade
Bergen Capital Australia, LLC
Koligo Therapeutics Ltd. Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia.	Health Technology
Brentridge Capital Pty Ltd.